Thursday 03 Apr, 2025 08:59 AM
Site map | Locate Us | Login
   Sky Gold board nod to incorporate a WOS in Dubai    Maruti Suzuki to hike car prices from April 8    LTIMindtree gains on joining hands with PHINIA Inc    Focus Lighting and Fixtures hits the roof after securing multiple orders worth Rs 9-cr    Godrej Properties rallies after selling homes worth over Rs 2,000 crore in Noida    Artson hits the roof on appointing Manoj Shah as CFO    Banco Products gains as arm expands production capacity in Poland    Gujarat Natural Resources jumps 47% in nine days    Central Bank of India leads losers in 'A' group    GPT Infra jumps on bagging order worth Rs 481-cr for railway project    Punjab & Sind Bank leads losers in 'B' group    Refex Renewables rallies on bagging Rs 65-cr tender    Surya Roshni's steel pipe & strips divions registers sales volume of 1,00,239 MT in March'25    Volumes jump at Quess Corp Ltd counter    Hi-Tech Pipes registers 24% YoY increase in FY25 sales volume; quartely sales at 1,16,032 MT 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Biocon's board to mull fund raising plans on 4 April
02-Apr-25   08:09 Hrs IST

The announcement was made after market hours yesterday.

Biocon is an innovation-led global biopharmaceuticals company engaged in the production of therapies for chronic conditions like diabetes, cancer, and autoimmune diseases. It has developed and commercialized novel biologics, biosimilars, and complex small-molecule APIs in India and several key global markets, as well as generic formulations in the US, Europe, & key emerging markets. It also has a pipeline of promising novel assets in immunotherapy under development.

The company had reported a consolidated net profit of Rs 25 crore in Q3 FY25, which is significantly lower as compared with the PAT of Rs 660 crore posted in Q3 FY24. Revenue from operations fell by 3% YoY to Rs 3,821 crore during the period under review.

The scrip shed 0.60% to end at Rs 339.15 on Tuesday, 1 April 2025.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 39946096
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd